How to vet a peptide supplier: a checklist for research labs
The research-peptide market is unregulated, inconsistently documented, and full of operators whose catalogs are indistinguishable from the catalogs of competent manufacturers. A lab that buys on price alone, or on web-design alone, will at some point buy a vial that is not what the label says.
This is a concrete checklist. Every item is a question you can ask, a document you can request, or a verification you can perform before placing an order. If a supplier cannot answer most of these, you have your answer about the supplier.
Documentation you should receive without asking
- A lot-specific COA. Not a generic product-level datasheet, a document that identifies the specific lot number on the vial and reports measured values, not aspirations.
- HPLC chromatogram. The actual chromatogram, not a summary statistic. Peaks, retention times, baseline.
- Mass-spec identity spectrum. The measured mass, with isotope pattern, matched to theoretical.
- Signed release. Named QC chemist and QA approver, with date of release.
- Storage and handling sheet. Recommended temperature, reconstitution guidance, stability data.
See How to read a peptide COA for a field guide to each line item.
Ten questions to ask before the first order
| Question | What a good answer looks like |
|---|---|
| Where is the peptide synthesized? | A named manufacturing partner and a specific facility location. |
| Who performs the release testing? | Either the manufacturer with independent audit, or a third-party lab by name. Not "our internal QC" with no further detail. |
| What reference standard do you use for HPLC identity? | A named commercial or in-house reference with a traceable COA of its own. |
| What is the limit of detection for impurity peaks? | A specific LOD, typically 0.1% or lower. "Impurities below detection" without a threshold is meaningless. |
| What is your policy on lot segregation? | New lot = new COA. No blending of lots to fill orders. |
| What is the retest policy? | A defined retest interval and a documented re-release procedure. |
| Do you carry product liability insurance? | Yes, with a named carrier and a coverage limit, not a hand-wave. |
| How do you handle out-of-spec results? | A documented OOS procedure with investigation, root-cause analysis, and disposition (release, reject, rework). |
| Can I audit? | Yes, with advance scheduling. A supplier that refuses site visits is a supplier that has something to hide. |
| What is your chain of custody after synthesis? | Sealed, tracked, refrigerated where indicated. A specific answer with handoff points named. |
Three verifications you can perform yourself
1. Cross-check the COA against a third-party lab
For any new supplier, send a sample of your first lot to an independent analytical lab (Alera, Intertek, Eurofins Covance all run peptide HPLC + MS). Compare the independent result to the supplier’s COA. Minor variance is normal (±0.3% HPLC purity between labs); a discrepancy greater than 2% suggests either a documentation error or a substituted material.
2. Check the physical vial
- Lot number on the vial matches the lot number on the COA.
- Fill weight, if stated, matches your own gravimetric check after equilibration.
- Powder is fluffy and free-flowing for a properly lyophilized peptide. Cake is acceptable; liquid residue is not.
- Closure is intact, septum is unpunctured, tamper seal is present.
3. Look up the supplier
- Business registration in the jurisdiction they claim to operate from.
- Physical address that is not a residential address or a mail-drop.
- Named company officers, at minimum a CEO or technical lead, who exist on LinkedIn or in a regulatory filing.
- Any published work, third-party reviews in research-community forums, or citations in primary literature.
A supplier that will not tell you where their peptide is made, who tests it, or who signs the COA is not a supplier. It is a shipping address.
Red flags that should end the conversation
- No lot-specific COA.
- COA with no chromatogram, or with a chromatogram that appears in every lot’s COA unchanged.
- Identical “as measured” values across many lots, real measurements have natural variance.
- Claims of pharmaceutical-grade or GMP-compliant production without certification.
- Prices substantially below the market floor for the compound class.
- Refusal or inability to answer any of the ten questions above.
- Marketing copy that describes the peptide’s effects in humans (a research-grade supplier does not market to end users).
See seven COA red flags for document-level diagnostics.
What a credible supplier should provide by default
Against the checklist above, a credible supplier should provide: lot-specific COA with full chromatogram, ESI-MS identity confirmation, RP-HPLC purity against a documented acceptance criterion, signed release, full synthesis provenance, and a named QC chemist of record. Every lot. Without being asked. Where we stand: our Freedom Diagnostics reports show the chromatogram, mass-spec identity and purity. Our older supplier-ordered Janoshik reports do not. None of our reports includes a signed release or a named QC chemist. The public lot ledger shows which report each lot has.
Related reading
Research use only. The guidance here is for evaluating suppliers of research-grade material. Clarion peptides are not drugs and are not supplied for human or veterinary use.
